Search results for "Mace"

showing 10 items of 4713 documents

Stability of tacrolimus ophthalmic solution

2017

Purpose The stability of 0.3-mg/mL tacrolimus ophthalmic solution at different storage temperatures was studied. Methods A sterile ophthalmic solution of 0.3 mg/mL tacrolimus was prepared in triplicate under aseptic conditions by diluting tacrolimus in eye drops. Three aliquots of this solution were transferred into polypropylene bottles and stored at 25, 2–8, or −15 to −25 °C. Samples were collected immediately after preparation and at selected time points and assayed in triplicate using high-performance liquid chromatography (HPLC). Samples were also visually examined for macroscopic changes. The 0.3-mg/mL tacrolimus solution was also exposed to acidic treatment and heat to force its degr…

Drug Storagemedicine.medical_treatmentAdministration Ophthalmicchemical and pharmacologic phenomena030226 pharmacology & pharmacyHigh-performance liquid chromatographyTacrolimus03 medical and health sciences0302 clinical medicineDrug StabilitymedicineHumansChromatography High Pressure LiquidPharmacologyChromatographyChemistryHealth PolicyTemperatureEye dropTacrolimusPharmaceutical Solutionssurgical procedures operativeOphthalmic solutionsAnesthesia030221 ophthalmology & optometryAseptic processingOphthalmic SolutionsImmunosuppressive AgentsAmerican Journal of Health-System Pharmacy
researchProduct

La prescripción farmacéutica en atención primaria. Informe SESPAS 2012

2012

ResumenEn 2010, el Sistema Nacional de Salud (SNS) facturó 958 millones de recetas. Dada la masiva exposición de la población a los medicamentos, los riesgos asociados a su consumo adquieren una enorme relevancia desde la perspectiva de salud pública. Pacientes sobremedicados en situaciones de bajo riesgo e inframedicados en situaciones de indicación demostrada, deficientemente informados, polimedicados, automedicados y un porcentaje no despreciable que sufre efectos adversos evitables, es en buena parte la fotografía de la prescripción en atención primaria que puede mejorarse. Sorprendentemente, la mayor parte de las estrategias farmacéuticas en el SNS no se han orientado al control de est…

Drug UtilizationPolypharmacymedicine.medical_specialtybusiness.industryMedical recordPublic healthPublic Health Environmental and Occupational HealthPrescription managementmedicine.diseaseAtención primariaPrimary carePrescriptionPharmaceutical expenditureGestión de la prescripciónGasto farmacéuticoPrescripciónHealth caremedicineAppropriatenessMedical emergencyMedical prescriptionbusinessPharmaceutical industrySelf-medicationAdecuaciónGaceta Sanitaria
researchProduct

Current status in buccal drug delivery

2008

This article overviews the progress made in buccal drug delivery research during the last five years and reports a new high-tech approach to achieve controlled delivery.

Drug permeationSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoBuccal drug deliverySettore MED/50 - Scienze Tecniche Mediche ApplicateIntelliDrug deviceBuccal drug delivery; Drug permeation; Promoting buccal absorption; IntelliDrug devicePromoting buccal absorption
researchProduct

Tailoring the physicochemical properties of core-crosslinked polymeric micelles for pharmaceutical applications.

2016

To optimally exploit the potential of (tumor-) targeted nanomedicines, platform technologies are needed in which physicochemical and pharmaceutical properties can be tailored according to specific medical needs and applications. We here systematically customized the properties of core-crosslinked polymeric micelles (CCPM). The micelles were based on mPEG-b-pHPMAmLacn (i.e. methoxy poly(ethylene glycol)-b-poly[N-(2-hydroxypropyl) methacrylamide-lactate]), similar to the block copolymer composition employed in CriPec® docetaxel, which is currently in phase I clinical trials. The CCPM platform was tailored with regard to size (30 to 100 nm), nanocarrier degradation (1 month to 1 year) and drug…

Drug targetingPolymersPharmaceutical ScienceNanotechnology02 engineering and technologyDocetaxel010402 general chemistry01 natural sciencesMicellechemistry.chemical_compoundCopolymerMicelleschemistry.chemical_classificationAcrylamidesDrug CarriersPolymerDrug release021001 nanoscience & nanotechnology0104 chemical sciencesMolecular WeightDrug LiberationNanomedicineCross-Linking ReagentschemistryTargeted drug deliveryDoxorubicin2023 OA procedureNanomedicinePolymeric micellesTaxoidsCore-crosslinkingNanocarriers0210 nano-technologyDrug carrierEthylene glycolJournal of controlled release : official journal of the Controlled Release Society
researchProduct

Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium

2013

Current malaria therapeutics demands strategies able to selectively deliver drugs to Plasmodium-infected red blood cells (pRBCs) in order to limit the appearance of parasite resistance. Here, the poly(amidoamines) AGMA1 and ISA23 have been explored for the delivery of antimalarial drugs to pRBCs. AGMA1 has antimalarial activity per se as shown by its inhibition of the in vitro growth of Plasmodium falciparum, with an IC50 of 13.7 μM. Fluorescence-assisted cell sorting data and confocal fluorescence microscopy and transmission electron microscopy images indicate that both polymers exhibit preferential binding to and internalization into pRBCs versus RBCs, and subcellular targeting to the par…

Drug3003PlasmodiumPolyamineErythrocytesPrimaquinemedia_common.quotation_subjectmalariaPharmaceutical ScienceAntimalarialPrimaquinePharmacologyParasitemiatargeted drug deliveryAntimalarialsMiceChloroquineparasitic diseasesPolyaminesmedicineAnimalsInternalizationDrug Carriermedia_commonDrug CarriersMice Inbred BALB CbiologyAnimalPlasmodium falciparumChloroquinePoly(amidoamine)polyamidoaminebiology.organism_classificationnanomedicineErythrocyteTargeted drug deliveryFemalepolymer-drug carrierPlasmodium yoeliimedicine.drug
researchProduct

Core-Shell Arginine-Containing Chitosan Microparticles for Enhanced Transcorneal Permeation of Drugs

2019

Chitosan oligosaccharide (C) was functionalized with L-arginine (A) and short hydrocarbon chains (C-8) to design an amphiphilic copolymer, henceforth CAC(8), leading to microparticles (MPs) consisting of an arginine-decorated hydrophilic shell and inner hydrophobic domains allowing the encapsulation of high amount hydrophobic drugs such as sorafenib tosylate (>10% w/w). L-arginine side chains were selected in order to impart the final MPs enhanced transcorneal penetration properties, thus overcoming the typical biological barriers which hamper the absorption of drugs upon topical ocular administration. The mucoadhesive properties and drug release profile of the CAC(8) MPs (CAC(8)-MPs) were …

Drug3003congenital hereditary and neonatal diseases and abnormalitiesArginineSwinemedia_common.quotation_subjectamphiphilic copolymerPharmaceutical ScienceL-arginineAdministration Ophthalmic02 engineering and technologyArginine030226 pharmacology & pharmacyCorneaChitosan03 medical and health scienceschemistry.chemical_compoundDrug Delivery Systems0302 clinical medicineMucoadhesionSide chainAnimalsskin and connective tissue diseasesProtein Kinase Inhibitorsmedia_commonMucin-3microparticlesDrug CarriersMucinnutritional and metabolic diseasesSorafenibPermeation021001 nanoscience & nanotechnologyCombinatorial chemistryBioavailabilityDrug LiberationmicroparticlechemistrySettore CHIM/09 - Farmaceutico Tecnologico Applicativoocular administrationchitosan0210 nano-technologymucoadhesion
researchProduct

3D-Printed Solid Dispersion Drug Products.

2019

With the well-known advantages of additive manufacturing methods such as three-dimensional (3D) printing in drug delivery, it is disappointing that only one product has been successful in achieving regulatory approval in the past few years. Further research and development is required in this area to introduce more 3D printed products into the market. Our study investigates the potential of fixed dose combination solid dispersion drug products generated via 3D printing. Two model drugs&mdash

Drug3d printedMaterials sciencemedia_common.quotation_subjecteducationPharmaceutical Science3D printing02 engineering and technology030226 pharmacology & pharmacyPolyvinyl alcoholArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicineamorphous solid dispersionfixed dose combinationmedia_commonbusiness.industry3D printing021001 nanoscience & nanotechnologySolventpoor solubilitychemistryChemical engineeringDrug deliveryManufacturing methods0210 nano-technologybusinessDispersion (chemistry)additive manufacturingPharmaceutics
researchProduct

Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors?

2009

The renin-angiotensin-aldosterone system (RAAS) plays a dominant role in the pathophysiology of hypertension, diabetes mellitus, chronic kidney disease and chronic heart failure. Therefore, drugs that block key components of the RAAS such as ACE inhibitors (ACEI) and angiotensin receptor blockers (ARBs) have gained wide clinical use for these indications. Despite progress, the morbidity and mortality of patients treated with ACEI or ARBs remain high. Aliskiren (Tekturna, Rasilez) is the first orally active inhibitor of renin approved for clinical use as an antihypertensive agent. The development program has established that at the licensed doses of 150 mg and 300 mg. Aliskiren is effective …

DrugACE inhibitorsmedia_common.quotation_subjectPharmaceutical Sciencelcsh:Medicinelcsh:RS1-441ReviewPharmacologylcsh:Pharmacy and materia medicachemistry.chemical_compoundRAS systemDiabetes mellitusDrug DiscoveryRenin–angiotensin systemmedicinecardiovascular diseasesmedia_commonbusiness.industrylcsh:RAliskirenmedicine.diseaseangiotensin receptor blockerschemistryPathophysiology of hypertensionHeart failureMolecular MedicineAngiotensin Receptor BlockersbusinessaliskirenKidney diseasePharmaceuticals
researchProduct

Pharmacogenomic and molecular docking studies on the cytotoxicity of the natural steroid wortmannin against multidrug-resistant tumor cells

2014

Wortmannin is a cytotoxic compound derived from the endophytic fungi Fusarium oxysporum, Penicillium wortmannii and Penicillium funiculosum that occurs in many plants, including medicinal herbs. The rationale to develop novel anticancer drugs is the frequent development of tumor resistance to the existing antineoplasic agents. Therefore, it is mandatory to analyze resistance mechanisms of novel drug candidates such as wortmannin as well to bring effective drugs into the clinic that have the potential to bypass or overcome resistance to established drugs and to substantially increase life span of cancer patients. In the present project, we found that P-glycoprotein-overexpressing tumor cells…

DrugATP Binding Cassette Transporter Subfamily BClass I Phosphatidylinositol 3-Kinasesmedia_common.quotation_subjectPharmaceutical ScienceAntineoplastic AgentsATP-binding cassette transporterDrug resistancePharmacologyBiologyWortmanninPhosphatidylinositol 3-Kinaseschemistry.chemical_compoundCell Line TumorDrug DiscoveryCluster AnalysisHumansCytotoxicityProtein kinase BPI3K/AKT/mTOR pathwayOligonucleotide Array Sequence Analysismedia_commonPharmacologyDrug Resistance MultipleAndrostadienesMolecular Docking SimulationMultiple drug resistanceComplementary and alternative medicinechemistryDrug Resistance NeoplasmPharmacogeneticsMolecular MedicineWortmanninSignal TransductionPhytomedicine
researchProduct

Drug gastrointestinal absorption in rat: Strain and gender differences.

2015

Predictive animal models of intestinal drug absorption are essential tools in drug development to identify compounds with promising biopharmaceutical properties. In situ perfusion absorption studies are routinely used in the preclinical setting to screen drug candidates. The objective of this work is to explore the differences in magnitude and variability on intestinal absorption associated with rat strain and gender. Metoprolol and Verapamil absorption rate coefficients were determined using the in situ closed loop perfusion model in four strains of rats and in both genders. Strains used were Sprague-Dawley, Wistar-Han, Wistar-Unilever, Long-Evans and CD∗IGS. In the case of Metoprolol only…

DrugAbsorption (pharmacology)Malemedia_common.quotation_subjectPharmaceutical SciencePharmacologyIntestinal absorptionRats Sprague-DawleySpecies SpecificitymedicineAnimalsRats Long-EvansRats Wistarmedia_commonMetoprololSex CharacteristicsIntestinal permeabilityChemistrymedicine.diseaseIntestinal AbsorptionVerapamilPermeability (electromagnetism)VerapamilFemalePerfusionmedicine.drugMetoprololEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct